The Use of PulseNmore FC Device in Patients Undergoing IVF Treatment A Study to Evaluate the Safety and the Efficacy

NARecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

December 1, 2022

Primary Completion Date

July 30, 2024

Study Completion Date

December 30, 2025

Conditions
Women Undergoing Fertility Treatments
Interventions
DEVICE

PulseNmore FC

"Pulsenmore Ltd. has developed a small portable vaginal ultrasound device for personal use at home. The ultrasound device allows to scan and assess both the uterus and the ovaries. This ultrasound device connects to a smartphone and a user-friendly application simplifies its use. This ultrasound device is based on the company's 'Pulsenmore ES ultrasound system' which is a small abdominal ultrasound device for home and self-use by pregnant women. This (abdominal) ultrasound device allows scanning and detection of fetal pulse, count fetal movements, assess the amount of amniotic fluid and more. The device is an abdominal ultrasound probe that connects to a smartphone using a specially designed socket. The main difference between the devices is the different design of the ultrasound vaginal probe.~The device consists of 2 components: a cradle and an application (software). The cradle contains the electronic components and the ultrasound probe."

Trial Locations (1)

Unknown

RECRUITING

Rabin Medical Center, Petah Tikva

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

PulseNmore

INDUSTRY

lead

Rabin Medical Center

OTHER

NCT05485623 - The Use of PulseNmore FC Device in Patients Undergoing IVF Treatment A Study to Evaluate the Safety and the Efficacy | Biotech Hunter | Biotech Hunter